Pluri Correlations
| PLUR Stock | USD 4.72 0.11 2.39% |
The current 90-days correlation between Pluri Inc and Enlivex Therapeutics is 0.13 (i.e., Average diversification). The correlation of Pluri is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Pluri Correlation With Market
Modest diversification
The correlation between Pluri Inc and DJI is 0.21 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Pluri Inc and DJI in the same portfolio, assuming nothing else is changed.
Pluri |
Moving against Pluri Stock
| 0.37 | CDIOW | Cardio Diagnostics | PairCorr |
| 0.32 | DRTS | Alpha Tau Medical | PairCorr |
| 0.4 | VTGN | VistaGen Therapeutics | PairCorr |
| 0.34 | SRZNW | Surrozen Warrant | PairCorr |
| 0.31 | VRAX | Virax Biolabs Group | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Pluri Stock performing well and Pluri Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Pluri's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| BLRX | 5.17 | (1.32) | 0.00 | (2.46) | 0.00 | 9.73 | 60.21 | |||
| PPBT | 3.45 | (0.63) | 0.00 | (0.85) | 0.00 | 6.69 | 23.14 | |||
| ARDS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| ENLV | 2.75 | 0.23 | 0.04 | 0.02 | 3.53 | 5.98 | 31.50 | |||
| TRGNF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| EPRXF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| CSBR | 4.73 | 1.36 | 0.26 | 1.13 | 4.44 | 10.88 | 33.14 | |||
| MAIA | 3.42 | (0.32) | 0.00 | (1.31) | 0.00 | 7.07 | 26.04 | |||
| LUMO | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| EVGN | 3.71 | 0.24 | 0.06 | 0.09 | 3.56 | 7.59 | 23.77 |
Pluri Corporate Management
| Lior Raviv | Chief Officer | Profile | |
| Nimrod Zvi | Chief Officer | Profile | |
| John Dvor | Executive America | Profile | |
| Liat Zalts | Chief Treasurer | Profile | |
| Efrat LivneHadass | Vice Resources | Profile | |
| Orly Amiran | Chief Officer | Profile |